MARAGANORE JOHN

Filings at 3 companies/Director · Rapport Therapeutics, Inc.

5 of 8 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 8. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The 5 most recent of 8 visible filings, newest first.

Rapport Therapeutics, Inc. Director
$31,547Open-market buy
TradedOct 22, 2026FiledOct 22, 2026
Rapport Therapeutics, Inc. Director
$217,344Open-market buy
TradedOct 22, 2026FiledOct 22, 2026
CITY THERAPEUTICS, INC. Director
56,095 sharesConversion
TradedOct 19, 2026FiledOct 19, 2026
CITY THERAPEUTICS, INC. Director
500,000 sharesConversion
TradedOct 19, 2026FiledOct 19, 2026
CITY THERAPEUTICS, INC. Director
22,649 sharesGrant
TradedOct 15, 2026FiledOct 19, 2026